ILA-CM14RB-100μg / 询价
ILA-CM14RB-500μg / 询价
ILA-CM14RB-500μgx2 / 询价
- 关联产品
- 客服电话
- 技术支持
Biotinylated Cynomolgus IL-4 R alpha/CD124 Protein (Primary Amine Labeling)
Recombinant Biotinylated Cynomolgus IL-4 R alpha/CD124 Protein (Primary Amine Labeling) is expressed from HEK293 with His tag at the C-terminus.It contains Met26-Arg232 [Accession | G7Q0S7].
The protein has a predicted MW of 24.84 kDa. Due to glycosylation, the protein migrates to 48-68 kDa based on Bis-Tris PAGE result.
>95% as determined by Bis-Tris PAGE
>95% as determined by HPLC
Less than 1EU per μg by the LAL method.
Supplied as 0.22 μm filtered solution in PBS (pH 7.4).
Valid for 12 months from date of receipt when stored at -80°C.
Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Biotinylated Cynomolgus IL-4 R alpha on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Biotinylated Cynomolgus IL-4 R alpha is greater than 95% as determined by SEC-HPLC.
Immobilized Cynomolgus IL-4, His Tag at 5μg/ml (100μl/well) on the plate. Dose response curve for Biotinylated Cynomolgus IL-4 R alpha, His Tag with the EC50 of 0.37μg/ml determined by ELISA (QC Test).
Interleukin 4 Receptor alpha (IL-4 Ra), also known as CD124 and BSF receptor, is a widely expressed 140 kDa transmembrane glycoprotein in the class I cytokine receptor family. The effects of IL-4 are mediated after binding to high affinity receptor complexes present on hematopoietic as well as non-hematopoietic cells.
CD124; IL-4 R alpha; IL-4R subunit alpha; IL4R; IL-4Ra; IL4RACD124
(1) Ghoreschi K , Thomas P , Breit S , et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease[J]. Nature Medicine, 2002, 9(1):40-46.
